Christopher B. Prentiss, Chief Accounting Officer at Adamas Pharmaceuticals Inc (ADMS), sold 228 shares at $7.51 ($2K) on 2018-12-20, disclosed to the SEC on 2018-12-26.
Open-market sale of $2k ADMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADMS | SELL | 2021-01-22 | $12K | — | Filing → |
| ADMS | SELL | 2020-11-02 | $7K | — | Filing → |
| ADMS | SELL | 2020-01-23 | $8K | — | Filing → |